65
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch

, , , , &
Pages 69-77 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Anne Tschacher, Cordula Cadus, Sebastian Schildge, Jens Peter Diedrich, Prashant N. Chhajed, Anne B. Leuppi-Taegtmeyer & Jörg Daniel Leuppi. (2021) Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Current Medical Research and Opinion 37:11, pages 2019-2033.
Read now
Wei Zhang, Lili Xu, Shen Gao, Nan Ding, Ping Shu, Zhuo Wang & Yuping Li. (2020) Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1471-1479.
Read now
Gary T. Ferguson & Richard N. Dalby. (2018) Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease. Postgraduate Medicine 130:6, pages 515-522.
Read now
Pieter Nicolaas Richard Dekhuijzen, Federico Lavorini & Omar S Usmani. (2016) Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®. Patient Preference and Adherence 10, pages 1561-1572.
Read now
Rüdiger Sauer, Michaela Hänsel, Roland Buhl, Roman A Rubin, Marcel Frey & Thomas Glaab. (2016) Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 891-898.
Read now
Andrea S Melani. (2015) Long-acting muscarinic antagonists. Expert Review of Clinical Pharmacology 8:4, pages 479-501.
Read now

Articles from other publishers (1)

Takashi Iwanaga, Yuji Tohda, Shuhei Nakamura & Yasunori Suga. (2019) The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients. Clinical Drug Investigation 39:11, pages 1021-1030.
Crossref